Baxter Bros Inc Vertex Pharmaceuticals Inc Transaction History

Baxter Bros Inc

$762 Million
Q3 2024

A detailed history of Baxter Bros Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Baxter Bros Inc holds 1,032 shares of VRTX stock, worth $485,411. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,032

Previous 980 5.31%

Holding current value

$485,411

Previous $459,000 4.36%

% of portfolio

0.06%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$460.0 - $505.78 $23,920 - $26,300	52 Added 5.31%	1,032 $479,000
Q2 2024 Jul 15, 2024	SELL	$392.81 - $485.53 $18,069 - $22,334	-46 Reduced 4.48%	980 $459,000
Q1 2024 Apr 26, 2024	BUY	$407.69 - $446.08 $52,999 - $57,990	130 Added 14.51%	1,026 $428,000
Q4 2023 May 17, 2024	SELL	$343.0 - $410.68 $44,590 - $53,388	-130 Reduced 12.67%	896 $364,000
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $26,068 - $31,211	76 Added 9.27%	896 $364,000
Q3 2023 May 17, 2024	SELL	$338.18 - $362.46 $69,665 - $74,666	-206 Reduced 20.08%	820 $285,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $19,259 - $21,970	-68 Reduced 7.66%	820 $258,000
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $285 - $321	-1 Reduced 0.11%	888 $256,000
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $102,686 - $114,573	-375 Reduced 29.67%	889 $257,000
Q2 2022 Jul 25, 2022	SELL	$234.96 - $292.55 $41,118 - $51,196	-175 Reduced 12.16%	1,264 $356,000
Q1 2022 Apr 20, 2022	SELL	$221.42 - $260.97 $33,213 - $39,145	-150 Reduced 9.44%	1,439 $376,000
Q4 2021 Jan 14, 2022	SELL	$177.01 - $223.45 $53,103 - $67,035	-300 Reduced 15.88%	1,589 $349,000
Q3 2021 Oct 25, 2021	SELL	$181.39 - $202.99 $238,527 - $266,931	-1,315 Reduced 41.04%	1,889 $343,000
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $40,122 - $47,315	-214 Reduced 6.26%	3,204 $646,000
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $48,649 - $56,707	235 Added 7.38%	3,418 $734,000
Q4 2020 Jan 25, 2021	BUY	$207.01 - $276.09 $658,912 - $878,794	3,183 New	3,183 $752,000

Others Institutions Holding VRTX

# of Institutions

1,714

Shares Held

226M

Call Options Held

1.21M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account